EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nasal biomarkers of immune function differ based on smoking and respiratory disease status

Meghan E Rebuli iD, Anna Stanley Lee, Lina Nurhussien, Usman A Tahir, Wendy Y Sun, Adam J Kimple, Charles S Ebert, Martha Almond, Ilona Jaspers iD, Mary B Rice iD

Physiological Reports · 2023

DOI: 10.14814/phy2.15528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Meghan E Rebuli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Curriculum in Toxicology and Environmental Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Car…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Asthma, Sinusitis, Respiration Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Flight Attendant Medical Research Institute, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory biomarkers have the potential to identify airway injury by revealing inflammatory processes within the respiratory tract. Currently, there are no respiratory biomarkers suitable for clinical use to identify patients that warrant further diagnostic work‐up, counseling, and treatment for toxic inhalant exposures or chronic airway disease. Using a novel, noninvasive method of sampling the nasal epithelial lining fluid, we aimed to investigate if nasal biomarker patterns could distinguish healthy nonsmoking adults from active smokers and those with chronic upper and lower airway disease in this exploratory study. We compared 28 immune mediators from healthy nonsmoking adults ( n = 32), former smokers with COPD ( n = 22), chronic rhinosinusitis (CRS) ( n = 22), and smoking adults without airway disease ( n = 13). Using ANOVA, multinomial logistic regressions, and weighted gene co‐expression network analysis (WGCNA), we determined associations between immune mediators and each cohort. Six mediators (IL‐7, IL‐10, IL‐13, IL‐12p70, IL‐15, and MCP‐1) were lower among disease groups compared to healthy controls. Participants with lower levels of IL‐10, IL‐12p70, IL‐13, and MCP‐1 in the nasal fluid had a higher odds of being in the COPD or CRS group. The cluster analysis identified groups of mediators that correlated with disease status. Specifically, the cluster of IL‐10, IL‐12p70, and IL‐13, was positively correlated with healthy and negatively correlated with COPD groups, and two clusters were correlated with active smoking. In this exploratory study, we preliminarily identified groups of nasal mucosal mediators that differed by airway disease and smoking status. Future prospective, age‐matched studies that control for medication use are needed to validate these patterns and determine if nasosorption has diagnostic utility for upper and lower airway disease or injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaSinusitisRespiration DisordersAdultHumansInterleukin-10Interleukin-13BiomarkersChronic DiseaseSmokingImmunity

Stichwörter der Autor:innen

COPDCRScigarette smokingimmune mediatorsnasal mucosa

Substanzen

Interleukin-10Interleukin-13Biomarkers

Autor:innen und Institutionen

  • Department of Pediatrics and Curriculum in Toxicology and Environmental Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Meghan E Rebuli, Ilona Jaspers, Mary B Rice

Förderung

  • NIEHS NIH HHS
  • Flight Attendant Medical Research Institute
  • National Heart, Lung, and Blood Institute
  • National Institute of Environmental Health Sciences

Zitieren

APA

Rebuli, M. E., Stanley Lee, A., Nurhussien, L., Tahir, U. A., Sun, W. Y., Kimple, A. J., Ebert, C. S., Almond, M., Jaspers, I., & Rice, M. B. (2023). Nasal biomarkers of immune function differ based on smoking and respiratory disease status. Physiological Reports. https://doi.org/10.14814/phy2.15528

Vancouver

Rebuli ME, Stanley Lee A, Nurhussien L, Tahir UA, Sun WY, Kimple AJ, et al. Nasal biomarkers of immune function differ based on smoking and respiratory disease status. Physiological Reports. 2023. doi:10.14814/phy2.15528

BibTeX
@article{Rebuli2023,
  author = {Rebuli, Meghan E and Stanley Lee, Anna and Nurhussien, Lina and Tahir, Usman A and Sun, Wendy Y and Kimple, Adam J and Ebert, Charles S and Almond, Martha and Jaspers, Ilona and Rice, Mary B},
  title = {Nasal biomarkers of immune function differ based on smoking and respiratory disease status},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15528}
}
Kostenlos starten →